Targeting of Protein Persulfidation in Aging and Age-Related Disorders
Pharmaceutics · 07.10.2026 · 18 (10) · 1266
DOI: 10.3390/pharmaceutics18101266 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 07.10.2026. Verfasst von Martín Hugo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Innovation and Universities, European Cooperation in Science and Technology, Generalitat de Catalunya.
Abstract (Originalsprache)
Aging is associated with a progressive loss of proteostasis and increased susceptibility to neurodegenerative and metabolic disorders. Among the molecular mechanisms implicated in these processes, protein persulfidation, a hydrogen sulfide (H2S)-mediated cysteine modification, has emerged as a critical regulator of protein function and redox homeostasis. Recent studies demonstrate that aging is accompanied by a decline in persulfidation and a concomitant increase in irreversible cysteine hyperoxidation, leading to protein dysfunction and aggregation. Beyond its established role in protecting proteins from oxidative damage, persulfidation has recently been shown to regulate biomolecular condensation and liquid–liquid phase separation, suppressing the formation of pathological protein assemblies linked to aging and neurodegenerative diseases. Moreover, pharmacological approaches that enhance persulfidation, including stimulation of endogenous H2S production and treatment with ergothioneine, improve metabolic resilience, increase NAD+ levels, and promote healthspan in experimental models. In this review, we discuss emerging evidence linking loss of persulfidation to protein aggregation, biomolecular condensates, and age-related functional decline, and highlight therapeutic strategies aimed at restoring persulfidation as a promising avenue for healthy aging and disease intervention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.
- Institut de Biotecnologia i Biomedicina, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.
ORCID-Profile: Martín Hugo, Javier Garcia-Pardo
Förderung
- Ministry of Science, Innovation and Universities
- European Cooperation in Science and Technology
- Generalitat de Catalunya
- Spanish Ministry of Science and Innovation
- COST
Zitieren
APA
Hugo, M., & Garcia-Pardo, J. (2026). Targeting of Protein Persulfidation in Aging and Age-Related Disorders. Pharmaceutics, 18(10), 1266. https://doi.org/10.3390/pharmaceutics18101266
Vancouver
Hugo M, Garcia-Pardo J. Targeting of Protein Persulfidation in Aging and Age-Related Disorders. Pharmaceutics. 2026;18(10):1266. doi:10.3390/pharmaceutics18101266
BibTeX
@article{Hugo2026,
author = {Hugo, Martín and Garcia-Pardo, Javier},
title = {Targeting of Protein Persulfidation in Aging and Age-Related Disorders},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {10},
pages = {1266},
doi = {10.3390/pharmaceutics18101266}
}
EUVIMED